Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29484238 | 0.86 | GABRA1 (0.46) | GABRA1GABRB2MGLLLMNAMAPT | |
| SCHEMBL154994 | 0.86 | GABRA1 (0.46) | GABRA1GABRB2MGLLLMNAMAPT | |
| SCHEMBL3398396 | 0.82 | GABRA1 (0.43) | GABRA1GABRB2MGLLLMNAMAPT | |
| SCHEMBL3703551 | 0.80 | MGLL (0.45) | GABRA1GABRB2MGLLLMNAMAPT | |
| SCHEMBL30901799 | 0.80 | MGLL (0.45) | GABRA1GABRB2MGLLLMNAMAPT | |
| SCHEMBL30627912 | 0.79 | GABRA1 (0.40) | GABRA1GABRB2MGLLLMNAMAPT | |
| SCHEMBL3732757 | 0.79 | GABRA1 (0.40) | GABRA1GABRB2MGLLLMNAMAPT | |
| SCHEMBL709848 | 0.78 | MAPT (0.46) | GABRA1GABRB2MGLLLMNAMAPT | |
| SCHEMBL8099691 | 0.78 | MGLL (0.43) | GABRA1GABRB2MGLLLMNAMAPT | |
| SCHEMBL25474416 | 0.76 | MGLL (0.42) | GABRA1GABRB2MGLLLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080315155-A1 | Diamines Having Reduced Color | ALBEMARLE CORPORATION (US) | 2008-12-25 | — | — | US | disclosed |
| US-20080262187-A1 | Blends of Diamines Having Reduced Color | ALBEMARLE CORPORATION (US) | 2008-10-23 | — | — | US | disclosed |
| EP-1966122-A1 | DIAMINES HAVING REDUCED COLOR | Albermarle Corporation (US) | 2008-09-10 | — | — | EP | disclosed |
| EP-1966265-A2 | BLENDS OF DIAMINES HAVING REDUCED COLOR | Albermarle Corporation (US) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007079367-A1 | DIAMINES HAVING REDUCED COLOR | ALBEMARLE CORPORATION (US) | 2007-07-12 | — | — | WO | disclosed |
| WO-2007079365-A2 | BLENDS OF DIAMINES HAVING REDUCED COLOR | ALBEMARLE CORPORATION (US) | 2007-07-12 | — | — | WO | disclosed |
| EP-1070044-B1 | REDUCING THE COLORATION OF AROMATIC DIAMINES | ALBEMARLE CORP (US) | 2004-09-15 | — | — | EP | disclosed |
| EP-0993444-A1 | STABILIZATION OF (HYDROCARBYLTHIO)AROMATIC AMINES AGAINST ODOR FORMATION | ALBEMARLE CORPORATION (US) | 2000-04-19 | — | — | EP | disclosed |
| US-5874619-A | Reducing the coloration of aromatic diamines | ALBEMARLE CORPORATION (US) | 1999-02-23 | — | — | US | disclosed |
| WO-1998058908-A1 | STABILIZATION OF (HYDROCARBYLTHIO)AROMATIC AMINES AGAINST ODOR FORMATION | ALBEMARLE CORPORATION (US) | 1998-12-30 | — | — | WO | disclosed |
| US-5840984-A | Stabilization of (hydrocarbylthio) aromatic amines against odor formation | ALBEMARLE CORPORATION (US) | 1998-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262187-A1 | Blends of Diamines Having Reduced Color | DDT, DDC, AOC1 | GABRA1 2317/4885GABRB2 2343/4885MGLL 2112/4885 |
| US-20080315155-A1 | Diamines Having Reduced Color | DDT, DPYD, DDC | GABRA1 2356/4885GABRB2 2092/4885MGLL 3740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.